Inhibikase Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Oct 24 | Buy€461,796 | Amit Munshi | Individual | 365,000 | €1.27 | |
21 Oct 24 | Buy€183,453 | Arvind Kush | Individual | 145,000 | €1.27 | |
21 Oct 24 | Buy€1,847,185 | Roberto Bellini | Individual | 1,460,000 | €1.27 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 9,341 | 0.175% |
Hedge Funds | 496,547 | 9.28% |
Institutions | 521,573 | 9.75% |
Individual Insiders | 889,887 | 16.6% |
General Public | 3,430,978 | 64.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
889,229 | €1.2m | 0% | no data | |||
496,547 | €648.4k | 0.62% | 0.02% | |||
223,500 | €291.8k | 0% | 100.0% | |||
88,310 | €115.3k | -0.08% | no data | |||
57,888 | €75.6k | 25.8% | no data | |||
28,333 | €37.0k | 0% | 0.14% | |||
20,976 | €27.4k | 0.04% | 0.01% | |||
16,667 | €21.8k | 0% | no data | |||
15,633 | €20.4k | 0% | no data | |||
13,802 | €18.0k | 0% | 0.01% | |||
12,722 | €16.6k | 13.4% | no data | |||
11,455 | €15.0k | 0% | no data | |||
7,357 | €9.6k | -8.21% | no data | |||
1,984 | €2.6k | -10.7% | no data | |||
1,667 | €2.2k | 0.06% | no data | |||
658 | €859.0 | 0% | no data | |||
166 | €216.5 | 0% | no data | |||
30 | €39.1 | 20% | no data | |||
2 | €2.8 | 0% | no data |